Table 2.
Intended use | Clinical treatment of skin chronic wounds |
Device description | Nanotechnology-based medical device |
Expected efficacy | Tissue reparation with minimal scarring |
Quality | Control of the inter-individual response |
Contraindications | No serious adverse effect |
Preclinical testing | Cell adhesion and proliferation onto the systems |
Clinical testing | Therapeutic efficacy |